Iterative Fragment Assembly for High-Affinity Ligand Screening

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for drug discovery, particularly in fragment-based approaches, face challenges in efficiently generating high-affinity compounds by merging fragments due to difficulties in identifying suitable linking moieties, especially when protein targets are not amenable to structural studies, and require high investment in protein engineering and production.

Innovation Solution

A method for rapid screening of a large chemical space using an iterative fragment assembly approach that involves a library of test ligands with a 'bait' moiety linked to naïve test moieties, allowing for assembly reactions to be screened individually for affinity to a target receptor without the need for purification, under denaturing conditions, and with low reagent costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If fragment-based approaches are used to generate high-affinity compounds, then the complexity of identifying suitable linking moieties increases, but the efficiency of compound generation decreases

Engineering Contradiction:
Improvecomplexity of identifying linking moietiesVSAvoidefficiency of compound generation
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The patent applies preliminary action by pre-attaching a reactive handle to the bait fragment before the screening process. This pre-preparation of the fragment with the reactive handle eliminates the need to identify and optimize linking moieties during the screening process, thereby resolving the contradiction between the complexity of identifying linking moieties and the efficiency of compound generation.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If structure-based methods or Tethering with Extenders are used, then the precision of fragment identification improves, but the investment in protein engineering and production increases

Engineering Contradiction:
Improveprecision of fragment identificationVSAvoidinvestment in protein engineering and production
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent employs a chemical probe with a reactive handle that can be used under denaturing conditions, eliminating the need for expensive protein engineering and production infrastructure. This disposable chemical approach achieves comparable precision in fragment identification without the high investment required by structure-based methods, resolving the contradiction between measurement precision and ease of manufacture.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Quantity of substance

If conventional combinatorial chemistry is used to produce compound libraries, then the quantity of compounds generated increases, but the difficulty of deconvolution increases

Engineering Contradiction:
Improvequantity of compounds generatedVSAvoiddifficulty of deconvolution
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent segments the compound library into individual reaction products, each containing a unique bait fragment combined with a single library member. This segmentation allows direct correlation between the reaction product and its components, eliminating the need for complex deconvolution processes while maintaining high compound generation capacity, thus resolving the contradiction between quantity of substances and device complexity.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS10107798B2Methods of chemotype evolution
Publication Date: 2018.10.23 CARMOT THERAPEUTICS INC
  • US10107798B2 patent drawing
  • US10107798B2 patent drawing
  • US10107798B2 patent drawing

AI summary

Herein is described a method to rapidly screen a large chemical space for a compound that binds to a target protein through an iterative fragment assembly approach that can be performed at low reagent cost and without requiring purification of the assembled product. The method employs a library of test ligands each of which comprise a ‘bait’ molecule, which is known from prior art or prior screening to have some intrinsic affinity for the target protein, and a test moiety.